## Background: The purpose of this study was to determine the feasibility and efficacy of hyperfractionated accelerated radiotherapy (hfrcb) combined with simultaneous chemotherapy with weekly cisplatin (cddp) in locally advanced inoperable head and neck cancer. ## Methods: From august 1999 to de
β¦ LIBER β¦
Voice preservation and survival after accelerated hyperfractionated radiotherapy for advanced laryngeal cancer
β Scribed by D.A.L. Morgan; P.J. Bradley
- Publisher
- Elsevier Science
- Year
- 1989
- Tongue
- English
- Weight
- 120 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Hyperfractionated accelerated radiothera
β
Gabriele K. Beckmann; Florian Hoppe; Leo Pfreundner; Michael P. Flentje
π
Article
π
2004
π
John Wiley and Sons
π
English
β 267 KB
π 2 views
A feasibility study of 252Cf neutron bra
β
Yosh Maruyama; Mary G. Bowen; John R. Van Nagell; Holly H. Gallion; Paul Depries
π
Article
π
1994
π
Elsevier Science
π
English
β 760 KB
Organ Function and Quality of Life after
β
Arno Olthoff; Andreas Ewen; Hendrik Andreas Wolff; Robert Michael Hermann; Hilke
π
Article
π
2009
π
Springer
π
German
β 303 KB
Induction chemotherapy with paclitaxel a
β
Andreas Dietz; Volker Rudat; Jens Dreyhaupt; Maria Pritsch; Florian Hoppe; Rudol
π
Article
π
2008
π
Springer-Verlag
π
English
β 385 KB
Vascular endothelial growth factor and v
β
Antonio Rueda; Oscar Cazorla; Lidia PΓ©rez; Martina Γlvarez; Maximino Redondo; El
π
Article
π
2010
π
John Wiley and Sons
π
English
β 813 KB
## Abstract ## Background Vascular endothelial growth factor (VEGF) expression seems to be associated with worse overall survival in patients with head and neck squamous cell carcinoma. The purposes of this study were to assess the prognostic values of the immunohistochemical expression of VEGF an